This developmental plasticity represents both a window of vulnerability, where adverse nutritional or hormonal cues can program future metabolic disease by impairing hypothalamic responses to insulin and leptin (33, 35), and a window of opportunity for intervention. This evidence concerns the gene LEP and metabolic disease.